Search
Search
Close this search box.
Search
Close this search box.

trial

Bayer Considers Controversial Bankruptcy Scheme to Settle Roundup Lawsuits

Product Liability / March 22, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , ,

The controversy surrounding Bayer AG and its Roundup weedkiller continues to escalate as the company faces massive verdicts in non-Hodgkins lymphoma lawsuits. With a wave of additional trials set to take place throughout 2024, Bayer is reportedly considering a controversial bankruptcy scheme known as the “Texas two-step” to force settlements through the U.S. bankruptcy system. […]

Bayer Considers Controversial Bankruptcy Scheme to Settle Roundup Lawsuits Read More »

Philadelphia Jury Delivers $2.25 Billion Verdict in Latest Roundup Trial

Product Liability / February 1, 2024 / 3 minutes of reading / By / , , , , , , , , , ,

In a landmark verdict, a Philadelphia jury has awarded a staggering $2.25 billion in damages in a trial involving the popular weed killer Roundup. The plaintiff, John McKivison, a resident of Lycoming County, Pennsylvania, claimed that his prolonged exposure to Roundup caused him to develop non-Hodgkin’s lymphoma. This verdict marks the third significant ruling against

Philadelphia Jury Delivers $2.25 Billion Verdict in Latest Roundup Trial Read More »

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma

Product Liability / November 6, 2023 / 5 minutes of reading / By / , , , , , , , , ,

Earlier this week, pharmaceutical and biotechnology giant Bayer was ordered to pay $332 million in damages to a man who claimed his cancer was caused by exposure to the company’s Roundup weed killer. The verdict includes $7 million in compensatory damages and $325 million in punitive damages designed to punish the company for failing to

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma Read More »

Scroll to Top